172 related articles for article (PubMed ID: 38430868)
1. Reconciling the discrepancies in randomized data of combining immunotherapy and radiation therapy: Not all radiotherapy is created equal.
Chang JY; Verma V; Weichselbaum RR
Eur J Cancer; 2024 Apr; 201():113972. PubMed ID: 38430868
[TBL] [Abstract][Full Text] [Related]
2. Stereotactic ablative radiotherapy and immunotherapy combinations: turning the future into systemic therapy?
Walshaw RC; Honeychurch J; Illidge TM
Br J Radiol; 2016 Oct; 89(1066):20160472. PubMed ID: 27556933
[TBL] [Abstract][Full Text] [Related]
3. The optimism surrounding stereotactic body radiation therapy and immunomodulation.
Tharmalingam H; Hoskin PJ
Chin Clin Oncol; 2017 Sep; 6(Suppl 2):S9. PubMed ID: 28917247
[TBL] [Abstract][Full Text] [Related]
4. The role of immunotherapy in combination with oligometastasis-directed therapy: a narrative review.
Turchan WT; Chmura SJ
Ann Palliat Med; 2021 May; 10(5):6028-6044. PubMed ID: 33440982
[TBL] [Abstract][Full Text] [Related]
5. A Prospective Trial Evaluating the Safety and Systemic Response From the Concurrent Use of Radiation Therapy with Checkpoint Inhibitor Immunotherapy in Metastatic Non-Small Cell Lung Cancer.
Mattes MD; Eubank TD; Almubarak M; Wen S; Marano GD; Jacobson GM; Ma PC
Clin Lung Cancer; 2021 Jul; 22(4):268-273. PubMed ID: 33608212
[TBL] [Abstract][Full Text] [Related]
6. Advances in radiotherapy in bone metastases in the context of new target therapies and ablative alternatives: A critical review.
Gouveia AG; Chan DCW; Hoskin PJ; Marta GN; Trippa F; Maranzano E; Chow E; Silva MF
Radiother Oncol; 2021 Oct; 163():55-67. PubMed ID: 34333087
[TBL] [Abstract][Full Text] [Related]
7. Elective Nodal Irradiation Attenuates the Combinatorial Efficacy of Stereotactic Radiation Therapy and Immunotherapy.
Marciscano AE; Ghasemzadeh A; Nirschl TR; Theodros D; Kochel CM; Francica BJ; Muroyama Y; Anders RA; Sharabi AB; Velarde E; Mao W; Chaudhary KR; Chaimowitz MG; Wong J; Selby MJ; Thudium KB; Korman AJ; Ulmert D; Thorek DLJ; DeWeese TL; Drake CG
Clin Cancer Res; 2018 Oct; 24(20):5058-5071. PubMed ID: 29898992
[No Abstract] [Full Text] [Related]
8. Immunotherapy and stereotactic ablative radiotherapy (ISABR): a curative approach?
Bernstein MB; Krishnan S; Hodge JW; Chang JY
Nat Rev Clin Oncol; 2016 Aug; 13(8):516-24. PubMed ID: 26951040
[TBL] [Abstract][Full Text] [Related]
9. Abscopal Effect Following Immunotherapy and Combined Stereotactic Body Radiation Therapy in Recurrent Metastatic Head and Neck Squamous Cell Carcinoma: A Report of Two Cases and Literature Review.
Choi JS; Sansoni ER; Lovin BD; Lindquist NR; Phan J; Mayo LL; Ferrarotto R; Su SY
Ann Otol Rhinol Laryngol; 2020 May; 129(5):517-522. PubMed ID: 31875405
[TBL] [Abstract][Full Text] [Related]
10. Stereotatic radiotherapy in metastatic non-small cell lung cancer: Combining immunotherapy and radiotherapy with a focus on liver metastases.
Corrao G; Marvaso G; Ferrara R; Lo Russo G; Gugliandolo SG; Piperno G; Spaggiari L; De Marinis F; Orecchia R; Garassino MC; Jereczek-Fossa BA
Lung Cancer; 2020 Apr; 142():70-79. PubMed ID: 32120227
[TBL] [Abstract][Full Text] [Related]
11. Immunotherapy and radiotherapy for metastatic cancers.
Bang A; Schoenfeld JD
Ann Palliat Med; 2019 Jul; 8(3):312-325. PubMed ID: 30180743
[TBL] [Abstract][Full Text] [Related]
12. Stereotactic radiosurgery and immunotherapy in melanoma brain metastases: Patterns of care and treatment outcomes.
Gabani P; Fischer-Valuck BW; Johanns TM; Hernandez-Aya LF; Keller JW; Rich KM; Kim AH; Dunn GP; Robinson CG; Chicoine MR; Huang J; Abraham CD
Radiother Oncol; 2018 Aug; 128(2):266-273. PubMed ID: 29960685
[TBL] [Abstract][Full Text] [Related]
13. Stereotactic Ablative Radiotherapy Combined with Immune Checkpoint Inhibitors Reboots the Immune Response Assisted by Immunotherapy in Metastatic Lung Cancer: A Systematic Review.
Chicas-Sett R; Morales-Orue I; Castilla-Martinez J; Zafra-Martin J; Kannemann A; Blanco J; Lloret M; Lara PC
Int J Mol Sci; 2019 May; 20(9):. PubMed ID: 31052488
[No Abstract] [Full Text] [Related]
14. Alliance A082002 -a randomized phase II/III trial of modern immunotherapy-based systemic therapy with or without SBRT for PD-L1-negative, advanced non-small cell lung cancer.
Schild SE; Wang X; Bestvina CM; Williams T; Masters G; Singh AK; Stinchcombe TE; Salama JK; Wolf S; Zemla T; Duma N; Chun SG; Amini A; Kozono D; Watt C
Clin Lung Cancer; 2022 Jul; 23(5):e317-e320. PubMed ID: 35613998
[TBL] [Abstract][Full Text] [Related]
15. Combinatorial strategies of radiotherapy and immunotherapy in nasopharyngeal carcinoma.
Yeo ELL; Li YQ; Soo KC; Wee JTS; Chua MLK
Chin Clin Oncol; 2018 Apr; 7(2):15. PubMed ID: 29764160
[TBL] [Abstract][Full Text] [Related]
16. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
17. Stereotactic Ablative Radiation Therapy Combined With Immunotherapy for Solid Tumors.
Brooks ED; Schoenhals JE; Tang C; Micevic G; Gomez DR; Chang JY; Welsh JW
Cancer J; 2016; 22(4):257-66. PubMed ID: 27441745
[TBL] [Abstract][Full Text] [Related]
18. The Abscopal Effect of Stereotactic Radiotherapy and Immunotherapy: Fool's Gold or El Dorado?
Xing D; Siva S; Hanna GG
Clin Oncol (R Coll Radiol); 2019 Jul; 31(7):432-443. PubMed ID: 31005381
[TBL] [Abstract][Full Text] [Related]
19. Definitive Management of Oligometastatic Melanoma in a Murine Model Using Combined Ablative Radiation Therapy and Viral Immunotherapy.
Blanchard M; Shim KG; Grams MP; Rajani K; Diaz RM; Furutani KM; Thompson J; Olivier KR; Park SS; Markovic SN; Pandha H; Melcher A; Harrington K; Zaidi S; Vile R
Int J Radiat Oncol Biol Phys; 2015 Nov; 93(3):577-87. PubMed ID: 26461000
[TBL] [Abstract][Full Text] [Related]
20. Safety and Efficacy of PD-1/PD-L1 inhibitors combined with radiotherapy in patients with non-small-cell lung cancer: a systematic review and meta-analysis.
Geng Y; Zhang Q; Feng S; Li C; Wang L; Zhao X; Yang Z; Li Z; Luo H; Liu R; Lu B; Wang X
Cancer Med; 2021 Feb; 10(4):1222-1239. PubMed ID: 33465302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
